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P U B L I S H E D B Y E L S E V I E R I N C .CORRECTIONS
Vahanian A, Himbert D. Transcatheter Aortic Valve Implantation: Could It Be Done Without Prior Balloon
Valvuloplasty? J Am Coll Cardiol Intv 2011;4:758–9.
The term aortic valve block was incorrectly defined in the following sentences:
BAV may induce, per se, aortic valve block.
It is difficult, from the data in the literature, to know exactly how BAV-induced aortic valve blocks play
a role in the overall pacemaker implantation; however, the U.K. registry shows that balloon pre-dilation
is independently associated with the need for pacemaking after TAVI (7).
It should have been defined as:
BAV may induce, per se, AV block.
It is difficult, from the data in the literature, to know exactly how BAV-induced AV blocks play a role
in the overall pacemaker implantation; however, the U.K. registry shows that balloon pre-dilation is
independently associated with the need for pacemaking after TAVI (7).
We apologize for the error.
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In the Results, Clinical Outcome section on page 977, the following:
In the propensity-matched cohort, at 30 days, patients in the IVUS group had significantly lower rates of
death/MI, MACE, mortality, and MI than did the patients in the no-IVUS group. At 1-year follow-up,
the significant reduction in mortality with IVUS was no longer present; however, rates of death/MI,
MACE, and MI were still significantly lower in the IVUS group. At 2-year follow-up, there was a
significant reduction in death/MI and MI and numerically lower MACE in the IVUS group (p  0.06).
should have been:
n the propensity-matched cohort at 30 days, patients in the IVUS group had significantly lower rates of
eath/MI, MACE, and MI compared to patients in the no-IVUS group. At 1-year follow-up, rates of
eath/MI and MI were still significantly lower in the IVUS group. At 2-year follow-up, there was a
ignificant reduction in death/MI and MI and numerically lower MACE in the IVUS group (p  0.18).
he authors apologize for this error.
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